The Effect of Endogenous Cushing Syndrome on All-cause and Cause-specific Mortality
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Objective: We aimed to perform a systematic review and meta-analysis of all-cause and cause-specific mortality of patients with benign endogenous Cushing syndrome (CS). Methods: The protocol was registered in PROSPERO (CRD42017067530). PubMed, EMBASE, CINHAL, Web of Science, and Cochrane Central searches were undertaken from inception to January 2021. Outcomes were the standardized mortality ratio (SMR), proportion, and cause of deaths. The I2 test, subgroup analysis, and meta-regression were used to assess heterogeneity across studies. Results: SMR was reported in 14 articles including 3691 patients (13 Cushing disease [CD] and 7 adrenal CS [ACS] cohorts). Overall SMR was 3.0 (95% CI, 2.3-3.9; I2 = 80.5%) for all CS, 2.8 (95% CI, 2.1-3.7; I2 = 81.2%) for CD and 3.3 (95% CI, 0.5-6.6; I2 = 77.9%) for ACS. Proportion of deaths, reported in 87 articles including 19 181 CS patients (53 CD, 24 ACS, and 20 combined CS cohorts), was 0.05 (95% CI, 0.03-0.06) for all CS subtypes with meta-regression analysis revealing no differences between CS subtypes (P = .052). The proportion of deaths was 0.1 (10%) in articles published before 2000 and 0.03 (3%) in 2000 until the last search for CS (P < .001), CD (P < .001), and ACS (P = .01). The causes of death were atherosclerotic diseases and thromboembolism (43.4%), infection (12.7%), malignancy (10.6%), active disease (3.5%), adrenal insufficiency (3.0%), and suicide (2.2%). Despite improved outcomes in recent years, increased mortality from CS persists. The causes of death highlight the need to prevent and manage comorbidities in addition to treating hypercortisolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rayyan-a web and mobile app for systematic reviews.
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0384-4 · Cited by 26,092
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329
Power failure: why small sample size undermines the reliability of neuroscience
Button, K. S., Ioannidis, J. P. A., Mokrysz, C., Nosek, B. A., Flint, J., Robinson, E. S. J., & Munafò, M. R. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3475 · Cited by 7,641
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Self-citationBarendregt, J. J., Doi, S. A., Lee, Y. Y., Norman, R. E., & Vos, T. (2013) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2013-203104 · Cited by 2,169
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
Stijnen, T., Hamza, T. H., & Özdemir, P. (2010) · Statistics in Medicine · doi:10.1002/sim.4040 · Cited by 757
Schwarzer, G., Chemaitelly, H., Abu‐Raddad, L. J., & Rücker, G. (2019) · Research Synthesis Methods · doi:10.1002/jrsm.1348 · Cited by 625
Morbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622
Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study
Dekkers, O. M., Horváth-Puhó, E., Jørgensen, J. O. L., Cannegieter, S. C., Ehrenstein, V., Vandenbroucke, J. P., Pereira, A. M., & Sørensen, H. T. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3582 · Cited by 419
Meta-analysis of proportions using generalized linear mixed models.
Lin, L., & Chu, H. (2020) · Epidemiology · doi:10.1097/ede.0000000000001232 · Cited by 345
Clayton, R. N., Jones, P. W., Reulen, R. C., Stewart, P. M., Hassan-Smith, Z. K., Ntali, G., Karavitaki, N., Dekkers, O. M., Pereira, A. M., Bolland, M., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30005-5 · Cited by 208
Self-citationMortality and morbidity in Cushing's syndrome in New Zealand
Bolland, M. J., Holdaway, I. M., Berkeley, J. E., Lim, S., Dransfield, W. J., Conaglen, J. V., Croxson, M. S., Gamble, G. D., Hunt, P. J., & Toomath, R. J. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04124.x · Cited by 182
Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years
Hassan-Smith, Z. K., Sherlock, M., Reulen, R. C., Arlt, W., Ayuk, J., Toogood, A. A., Cooper, M. S., Johnson, A. P., & Stewart, P. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2957 · Cited by 153
Self-citationMortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up
Ntali, G., Asimakopoulou, A., Siamatras, T., Komninos, J., Vassiliadi, D., Tzanela, M., Tsagarakis, S., Grossman, A. B., Wass, J. A. H., & Karavitaki, N. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0569 · Cited by 149
Mortality in Cushing's syndrome: data from 386 patients from a single tertiary referral center
Yaneva, M., Kalinov, K., & Zacharieva, S. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0320 · Cited by 93
Research works printed but not linked: 52
- Hasenmajer, 2020, The immune system in Cushing’s syndrome, Trends Endocrinol Metab., 31, 655, 10.1016/j.tem.2020.04.004 · DOI · Paper page
- Raappana, 2010, Incidence of pituitary adenomas in Northern Finland in 1992-2007, J Clin Endocrinol Metab., 95, 4268, 10.1210/jc.2010-0537 · DOI · Paper page
- Boscaro, 2009, Approach to the patient with possible Cushing’s syndrome, J Clin Endocrinol Metab., 94, 3121, 10.1210/jc.2009-0612 · DOI · Paper page
- Lindholm, 2001, Incidence and late prognosis of Cushing’s syndrome: a population-based study, J Clin Endocrinol Metab., 86, 117
- Wengander, 2019, The incidence of endogenous Cushing’s syndrome in the modern era, Clin Endocrinol (Oxf)., 91, 263, 10.1111/cen.14014 · DOI
- Ragnarsson, 2019, Overall and disease-specific mortality in patients with Cushing disease: a Swedish nationwide study, J Clin Endocrinol Metab., 104, 2375, 10.1210/jc.2018-02524 · DOI · Paper page
- Ahn, 2021, Epidemiology and comorbidity of adrenal Cushing syndrome: a nationwide cohort study, J Clin Endocrinol Metab., 106, e1362, 10.1210/clinem/dgaa752 · DOI
- Arnardóttir, 2011, The incidence and prevalence of Cushing’s disease may be higher than previously thought: results from a retrospective study in Iceland 1955 through 2009, Clin Endocrinol (Oxf)., 74, 792, 10.1111/j.1365-2265.2010.03961.x · DOI
- Dekkers, 2007, Mortality in patients treated for Cushing’s disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma, J Clin Endocrinol Metab., 92, 976, 10.1210/jc.2006-2112 · DOI · Paper page
- Clayton, 2010, Mortality in Cushing’s disease, Neuroendocrinology., 92, 71, 10.1159/000315813 · DOI · Paper page
- Clayton, 2011, Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature, J Clin Endocrinol Metab., 96, 632, 10.1210/jc.2010-1942 · DOI · Paper page
- Graversen, 2012, Mortality in Cushing’s syndrome: a systematic review and meta-analysis, Eur J Intern Med., 23, 278, 10.1016/j.ejim.2011.10.013 · DOI
- Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration, BMJ., 339, b2700, 10.1136/bmj.b2700 · DOI · Paper page
- Shamseer, 2015, Preferred Reporting items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015: elaboration and explanation, BMJ., 350, g7647, 10.1136/bmj.g7647 · DOI · Paper page
- Bochicchio, 1995, Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing’s Disease Survey Group, J Clin Endocrinol Metab., 80, 3114
- Valassi, 2019, High mortality within 90 days of diagnosis in patients with Cushing’s syndrome: results from the ERCUSYN registry, Eur J Endocrinol., 181, 461, 10.1530/EJE-19-0464 · DOI · Paper page
- Terzolo, 2014, Surgical remission of Cushing’s syndrome reduces cardiovascular risk, Eur J Endocrinol., 171, 127, 10.1530/EJE-13-0555 · DOI · Paper page
- Dimopoulou, 2014, Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing’s disease: care reality in the Munich metropolitan region, Eur J Endocrinol., 170, 283, 10.1530/EJE-13-0634 · DOI · Paper page
- Torales, 2014, Endoscopic endonasal surgery for pituitary tumors. Results in a series of 121 patients operated at the same center and by the same neurosurgeon, Endocrinol Nutr., 61, 410, 10.1016/j.endonu.2014.03.011 · doi:10.1016/j.endonu.2014.03.011
- Reincke, 2015, A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing’s syndrome, Eur J Endocrinol., 173, M23, 10.1530/EJE-15-0265 · DOI
- Aranda, 2015, Long-term remission and recurrence rate in a cohort of Cushing’s disease: the need for long-term follow-up, Pituitary., 18, 142, 10.1007/s11102-014-0567-8 · DOI
- de La Villéon, 2016, Long-term outcome after adrenalectomy for incidentally diagnosed subclinical cortisol-secreting adenomas, Surgery., 160, 397, 10.1016/j.surg.2016.03.008 · DOI
- Solak, 2016, Management of Cushing’s disease: a single-center experience, Endocrine., 51, 517, 10.1007/s12020-015-0695-6 · DOI
- Brichard, 2018, Outcome of transsphenoidal surgery for Cushing disease: a single-center experience over 20 years, World Neurosurg., 119, e106, 10.1016/j.wneu.2018.07.055 · DOI
- Innovation VH, Covidence Systematic Review Software
- Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med., 21, 1539, 10.1002/sim.1186 · DOI · Paper page
- StataCorp, 2019, Stata Statistical Software: Release 16
- Miloslavsky, 2017, Development of a glucocorticoid toxicity index (GTI) using multicriteria decision analysis, Ann Rheum Dis., 76, 543, 10.1136/annrheumdis-2016-210002 · DOI · Paper page
- Nyaga, 2019, METAPREG: Stata module to compute fixed and random effects meta-analysis and meta-regression of proportions. Statistical Software Components
- Swearingen, 1999, Long-term mortality after transsphenoidal surgery for Cushing disease, Ann Intern Med., 130, 821, 10.7326/0003-4819-130-10-199905180-00015 · DOI · Paper page
- Hammer, 2004, Transsphenoidal microsurgery for Cushing’s disease: initial outcome and long-term results, J Clin Endocrinol Metab., 89, 6348, 10.1210/jc.2003-032180 · DOI · Paper page
- Pikkarainen, 1999, The survival and well-being of patients treated for Cushing’s syndrome, J Intern Med., 245, 463, 10.1046/j.1365-2796.1999.00483.x · DOI · Paper page
- Roldán-Sarmiento, 2021, Diabetes, active disease, and afternoon serum cortisol levels predict Cushing’s disease mortality: a cohort study, J Clin Endocrinol Metab., 106, e103, 10.1210/clinem/dgaa774 · DOI · Paper page
- van Haalen, 2015, Management of endocrine disease: Mortality remains increased in Cushing’s disease despite biochemical remission: a systematic review and meta-analysis, Eur J Endocrinol., 172, R143, 10.1530/EJE-14-0556 · DOI · Paper page
- Stroud, 2020, Outcomes of pituitary surgery for Cushing’s disease: a systematic review and meta-analysis, Pituitary., 23, 595, 10.1007/s11102-020-01066-8 · DOI
- Wagner, 2018, Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing’s syndrome: a systematic meta-analysis, Front Endocrinol (Lausanne)., 9, 805, 10.3389/fendo.2018.00805 · DOI · Paper page
- Papakokkinou, 2020, Excess morbidity persists in patients with Cushing’s disease during long-term remission: a Swedish nationwide study, J Clin Endocrinol Metab., 105, 2616, 10.1210/clinem/dgaa291 · DOI · Paper page
- Sharma, 2015, Comorbidities in Cushing’s disease, Pituitary., 18, 188, 10.1007/s11102-015-0645-6 · DOI · Paper page
- Barbot, 2019, The pathophysiology and treatment of hypertension in patients with Cushing’s syndrome, Front Endocrinol (Lausanne)., 10, 321, 10.3389/fendo.2019.00321 · DOI
- Ferraù, 2015, Metabolic comorbidities in Cushing’s syndrome, Eur J Endocrinol., 173, M133, 10.1530/EJE-15-0354 · DOI · Paper page
- Arnaldi, 2010, Pathophysiology of dyslipidemia in Cushing’s syndrome, Neuroendocrinology., 92, 86, 10.1159/000314213 · DOI · Paper page
- Tona, 2020, New insights to the potential mechanisms driving coronary flow reserve impairment in Cushing’s syndrome: a pilot noninvasive study by transthoracic Doppler echocardiography, Microvasc Res., 128, 103940, 10.1016/j.mvr.2019.103940 · DOI
- Neary, 2013, Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography, J Clin Endocrinol Metab., 98, 2045, 10.1210/jc.2012-3754 · DOI · Paper page
- Piasecka, 2020, Psychiatric and neurocognitive consequences of endogenous hypercortisolism, J Intern Med., 288, 168, 10.1111/joim.13056 · DOI
- Kelly, 1996, Psychiatric aspects of Cushing’s syndrome, QJM., 89, 543, 10.1093/qjmed/89.7.543 · DOI · Paper page
- Loosen, 1992, Psychiatric phenomenology in Cushing’s disease, Pharmacopsychiatry., 25, 192, 10.1055/s-2007-1014405 · DOI · Paper page
- Kelly, 1996, A prospective study of psychiatric and psychological aspects of Cushing’s syndrome, Clin Endocrinol (Oxf)., 45, 715, 10.1046/j.1365-2265.1996.8690878.x · DOI · Paper page
- Dorn, 1995, Psychopathology in patients with endogenous Cushing’s syndrome: ‘atypical’ or melancholic features, Clin Endocrinol (Oxf)., 43, 433, 10.1111/j.1365-2265.1995.tb02614.x · DOI · Paper page
- Bancos, 2015, Diagnosis and management of adrenal insufficiency, Lancet Diabetes Endocrinol., 3, 216, 10.1016/S2213-8587(14)70142-1 · DOI · Paper page
- Schernthaner-Reiter, 2021, Acute and life-threatening complications in Cushing’s syndrome: prevalence, predictors and mortality, J Clin Endocrinol Metab., 106, e2035, 10.1210/clinem/dgab058 · DOI · Paper page
- Lin, 2020, Arcsine-based transformations for meta-analysis of proportions: Pros, cons, and alternatives, Health Sci Rep., 3, e178, 10.1002/hsr2.178 · DOI · Paper page
- Limumpornpetch P, 2022, Supplementary data for “The effect of endogenous Cushing’s syndrome on all-cause and cause-specific mortality: a systematic review and meta-analysis.”, Figshare
Cited by
Diagnosis and Management of Pituitary Adenomas: A Review
Tritos, N. A., & Miller, K. K. (2023) · JAMA · doi:10.1001/jama.2023.5444 · Cited by 331
Reincke, M., & Fleseriu, M. (2023) · JAMA · doi:10.1001/jama.2023.11305 · Cited by 256
Vogel, F., Braun, L., Zopp, S., Nowak, E., Schreiner, J., Benz, I., Rubinstein, G., Künzel, H., Ritzel, K., Kroiss, M., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad041 · Cited by 28
Newell-Price, J., Fleseriu, M., Pivonello, R., Feelders, R. A., Gadelha, M. R., Lacroix, A., Witek, P., Heaney, A. P., Piacentini, A., Pedroncelli, A. M., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae201 · Cited by 21
“Hypercortisolism is also associated with an increased risk of mortality, primarily as a result of cardiovascular and infectious diseases [3, 8].”
Hinojosa-Amaya, J. M., González-Colmenero, F. D., Alvarez-Villalobos, N. A., Salcido-Montenegro, A., Quintanilla-Sánchez, C., Moreno-Peña, P. J., Manzanares-Gallegos, D. M., Gutiérrez-Dávila, L. F., Castillo-Morales, P. L., García-Campa, M., et al. (2024) · Pituitary · doi:10.1007/s11102-024-01408-w · Cited by 14
Metadata
- Authors
- Limumpornpetch, P., Morgan, A. W., Tiganescu, A., Baxter, P. D., Nyawira Nyaga, V., Pujades-Rodriguez, M., & Stewart, P. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2022-04-29
- Volume
- 107
- Issue
- 8
- Pages
- 2377-2388
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W4225137705
- Cited by
- 87
- References
- 16
- FWCI
- 9.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- National Institute for Health Research
- Leeds Biomedical Research Centre
- Medical Research Council
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.